Pub Date : 2024-01-26DOI: 10.29011/2577-1442.100051
{"title":"Association between Covid-19 Vaccines and Anxiety","authors":"","doi":"10.29011/2577-1442.100051","DOIUrl":"https://doi.org/10.29011/2577-1442.100051","url":null,"abstract":"","PeriodicalId":73859,"journal":{"name":"Journal of neurology and experimental neural science","volume":"9 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139594320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-02-24DOI: 10.29011/2577-1442.100048
{"title":"Changes in Depressive Symptoms and Perceived Stress in Women Coping with Infertility, Following Mind-Body Interventions","authors":"","doi":"10.29011/2577-1442.100048","DOIUrl":"https://doi.org/10.29011/2577-1442.100048","url":null,"abstract":"","PeriodicalId":73859,"journal":{"name":"Journal of neurology and experimental neural science","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136166345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.29011/2577-1442.100050
Daniel Sop, Joel L Steinberg, Jennifer Jordan, Taylor Crouch, Yue May Zhang, Wally Smith
Background and purpose: Compared to healthy controls, adult patients with Sickle Cell Disease (SCD) are anemic, and therefore have higher cardiac output and Cerebral Blood Flow (CBF) to maintain brain oxygenation. They also demonstrate comparatively more cognitive deficits due to either overt strokes or silent cerebral ischemia. However, there are few correlative studies between CBF and cognitive deficits, specifically processing speed in SCD. Such studies are important to develop biomarkers of central brain processing and ischemia for diagnosis, prognosis, and evaluating the effectiveness of potential interventions. This pilot cross-sectional study tested the hypotheses that adults with SCD and elevated CBF demonstrate lower central brain processing speed than controls on average and that CBF is inversely correlated with processing speed.
Methods: We conducted a pilot cross-sectional study to assess the relation-ships between CBF, central brain processing speed, and hemoglobin levels in asymptomatic adults with SCD and controls from an urban academic medical center. MRI acquisitions at 3T consisted of 2D phase-contrast quantitative arteriograms (Qflow) of the bilateral internal carotid and vertebral arteries and 3D pseudo-continuous arterial spin labeling (pCASL) of the brain. Participants were patients with SCD (hemoglobin [Hb]SS, [Hb] SBetaThal°, or [Hb]SC) aged 22-52 years of African American descent (N=7) or community controls (Hb AA) (n=3). Processing speed was assessed as an in-direct functional marker of ischemia using a recommended test from the NIH Toolbox for Assessment of Neurological and Behavioral Function, the Pattern Comparison Processing Speed Test. t-tests were used to compare means of CBF, hemoglobin, and cognition between SCD patients and healthy controls. Among SCD patients only multivariate correla-tions were used to evaluate relationships between brain perfusion in specific brain regions vs. processing speed and CBF. The significance level was set at p≤0.05.
Results: Adults with SCD reported higher CBF compared to healthy con-trols (72.15±28.90 vs. 47.23±12.30 ml/min/100g, p=0.04), and lower hemoglobin concentration (8.64±2.33 vs. 13.33±0.58, p=0.001). Heart rate in SCD patients was higher than in controls (86.29±1.37 vs. 74.00±2.10, p=0.04). Patients with SCD demonstrated lower processing speed (96.14±21.04 vs.123±13.74, p=0.02) than controls. Among adult patients with SCD, perfusion in specific regions of the brain showed an inverse relationship with processing speed, as did whole-brain CBF (p=0.0325).
Conclusion: These findings, although from a small sample, lend a degree of validity to the claim that processing speed is slower in people with SCD than in controls and that CBF is significantly higher in SCD patients com-pared to controls. The results also lend credence to the finding that the degree of processing speed deficiencies am
背景和目的:与健康对照相比,成年镰状细胞病(SCD)患者贫血,因此有更高的心输出量和脑血流量(CBF)来维持脑氧合。由于明显的中风或无症状的脑缺血,他们也表现出相对更多的认知缺陷。然而,脑卒中与认知缺陷,特别是认知加工速度之间的相关研究却很少。这些研究对于开发中枢脑加工和缺血的生物标志物,用于诊断、预后和评估潜在干预措施的有效性具有重要意义。本初步横断面研究验证了SCD和CBF升高的成人的中央脑处理速度低于平均对照组的假设,CBF与处理速度呈负相关。方法:我们进行了一项试验性横断面研究,以评估无症状SCD成人和城市学术医疗中心对照组的CBF、中央脑处理速度和血红蛋白水平之间的关系。3T时的MRI采集包括双侧颈内动脉和椎动脉的二维相位对比定量动脉图(Qflow)和大脑的三维伪连续动脉自旋标记(pCASL)。参与者为22-52岁非裔美国人后裔(N=7)或社区对照组(Hb AA)的SCD(血红蛋白[Hb]SS, [Hb] SBetaThal°或[Hb]SC)患者(N= 3)。处理速度被评估为缺血的间接功能标记,使用美国国立卫生研究院神经和行为功能评估工具箱推荐的测试,模式比较处理速度测试。采用t检验比较SCD患者与健康对照者的CBF、血红蛋白和认知水平。在SCD患者中,仅使用多变量相关性来评估特定脑区域的脑灌注与处理速度和CBF之间的关系。显著性水平设为p≤0.05。结果:SCD成人CBF高于健康对照组(72.15±28.90 vs. 47.23±12.30 ml/min/100g, p=0.04),血红蛋白浓度较低(8.64±2.33 vs. 13.33±0.58,p=0.001)。SCD患者心率高于对照组(86.29±1.37 vs. 74.00±2.10,p=0.04)。SCD患者的处理速度(96.14±21.04 vs.123±13.74,p=0.02)低于对照组。在成年SCD患者中,大脑特定区域的灌注与处理速度呈反比关系,全脑CBF也是如此(p=0.0325)。结论:这些发现,虽然来自一个小样本,但在一定程度上证明了SCD患者的处理速度比对照组慢,而SCD患者的CBF明显高于对照组。研究结果还证实了下述发现:成人SCD患者的处理速度缺陷程度与CBF升高程度相关,而CBF升高程度与SCD相关的贫血程度相对应。
{"title":"Association of Cerebral Hemodynamics and Anemia on Processing Speed in Adults with Sickle Cell Disease.","authors":"Daniel Sop, Joel L Steinberg, Jennifer Jordan, Taylor Crouch, Yue May Zhang, Wally Smith","doi":"10.29011/2577-1442.100050","DOIUrl":"https://doi.org/10.29011/2577-1442.100050","url":null,"abstract":"<p><strong>Background and purpose: </strong>Compared to healthy controls, adult patients with Sickle Cell Disease (SCD) are anemic, and therefore have higher cardiac output and Cerebral Blood Flow (CBF) to maintain brain oxygenation. They also demonstrate comparatively more cognitive deficits due to either overt strokes or silent cerebral ischemia. However, there are few correlative studies between CBF and cognitive deficits, specifically processing speed in SCD. Such studies are important to develop biomarkers of central brain processing and ischemia for diagnosis, prognosis, and evaluating the effectiveness of potential interventions. This pilot cross-sectional study tested the hypotheses that adults with SCD and elevated CBF demonstrate lower central brain processing speed than controls on average and that CBF is inversely correlated with processing speed.</p><p><strong>Methods: </strong>We conducted a pilot cross-sectional study to assess the relation-ships between CBF, central brain processing speed, and hemoglobin levels in asymptomatic adults with SCD and controls from an urban academic medical center. MRI acquisitions at 3T consisted of 2D phase-contrast quantitative arteriograms (Qflow) of the bilateral internal carotid and vertebral arteries and 3D pseudo-continuous arterial spin labeling (pCASL) of the brain. Participants were patients with SCD (hemoglobin [Hb]SS, [Hb] SBetaThal°, or [Hb]SC) aged 22-52 years of African American descent (N=7) or community controls (Hb AA) (n=3). Processing speed was assessed as an in-direct functional marker of ischemia using a recommended test from the NIH Toolbox for Assessment of Neurological and Behavioral Function, the Pattern Comparison Processing Speed Test. t-tests were used to compare means of CBF, hemoglobin, and cognition between SCD patients and healthy controls. Among SCD patients only multivariate correla-tions were used to evaluate relationships between brain perfusion in specific brain regions vs. processing speed and CBF. The significance level was set at p≤0.05.</p><p><strong>Results: </strong>Adults with SCD reported higher CBF compared to healthy con-trols (72.15±28.90 vs. 47.23±12.30 ml/min/100g, p=0.04), and lower hemoglobin concentration (8.64±2.33 vs. 13.33±0.58, p=0.001). Heart rate in SCD patients was higher than in controls (86.29±1.37 vs. 74.00±2.10, p=0.04). Patients with SCD demonstrated lower processing speed (96.14±21.04 vs.123±13.74, p=0.02) than controls. Among adult patients with SCD, perfusion in specific regions of the brain showed an inverse relationship with processing speed, as did whole-brain CBF (p=0.0325).</p><p><strong>Conclusion: </strong>These findings, although from a small sample, lend a degree of validity to the claim that processing speed is slower in people with SCD than in controls and that CBF is significantly higher in SCD patients com-pared to controls. The results also lend credence to the finding that the degree of processing speed deficiencies am","PeriodicalId":73859,"journal":{"name":"Journal of neurology and experimental neural science","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464389/pdf/nihms-1922726.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10121048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-05-09DOI: 10.29011/2577-1442.100046
E. Garofalo, M. Sannino, A. Iavarone, Bruno, Ronga
Effects of Dietary Supplementation with High-Dose Choline Alfoscerate (Cerebrain Forte) on Cognitive Functioning in Patients with Minor Neurocognitive Disorder (Mind): A Pilot Study. J Abstract Introduction and aim of the study: Normal and pathological aging have been related to deficits of several neurotransmitters able to account for cognitive, emotional and behavioral disorders associated with mild cognitive decline or overt dementia. Among the neurotransmitter deficits involved in cognitive disorders, with particular reference to those underlying memory and attentional functions, the cholinergic one is certainly the main one [1]. This justified the treatment of these disorders with drugs and supplements capable of enhancing cholinergic transmission by inhibiting the degradation of acetylcholine (acetylcholinesterase inhibitors) or by increasing the production of the neurotransmitter through the exogenous supply of precursors [2,3]. Choline Alfoscerate is at the forefront of these supplements. The effect of the supplements is dose-dependent, and it is therefore likely that a high-dose formulation is associated with effects on cognition of a higher entity than that with medium or medium-low dosages. Aim of this pilot study is to evaluate the effects of dietary supplementation
{"title":"Effects of Dietary Supplementation with High-Dose Choline Alfoscerate (Cerebrain® Forte) on Cognitive Functioning in Patients with Minor Neurocognitive Disorder (Mind): A Pilot Study","authors":"E. Garofalo, M. Sannino, A. Iavarone, Bruno, Ronga","doi":"10.29011/2577-1442.100046","DOIUrl":"https://doi.org/10.29011/2577-1442.100046","url":null,"abstract":"Effects of Dietary Supplementation with High-Dose Choline Alfoscerate (Cerebrain Forte) on Cognitive Functioning in Patients with Minor Neurocognitive Disorder (Mind): A Pilot Study. J Abstract Introduction and aim of the study: Normal and pathological aging have been related to deficits of several neurotransmitters able to account for cognitive, emotional and behavioral disorders associated with mild cognitive decline or overt dementia. Among the neurotransmitter deficits involved in cognitive disorders, with particular reference to those underlying memory and attentional functions, the cholinergic one is certainly the main one [1]. This justified the treatment of these disorders with drugs and supplements capable of enhancing cholinergic transmission by inhibiting the degradation of acetylcholine (acetylcholinesterase inhibitors) or by increasing the production of the neurotransmitter through the exogenous supply of precursors [2,3]. Choline Alfoscerate is at the forefront of these supplements. The effect of the supplements is dose-dependent, and it is therefore likely that a high-dose formulation is associated with effects on cognition of a higher entity than that with medium or medium-low dosages. Aim of this pilot study is to evaluate the effects of dietary supplementation","PeriodicalId":73859,"journal":{"name":"Journal of neurology and experimental neural science","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41577557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-02-09DOI: 10.29011/2577-1442.100045
Felipe Torres Obando, P. Romeo, D. Vergara, Fede G Di, Pardo, Adriana Soto
Rare and orphan diseases are a group of multiorgan disabilities that limit the life quality in young and adult patients, affecting the socio-economic burden for the families and the community. Despite the continuous attempts in research, no standardized and effective therapies are nowadays available. Orthosis supports and rehabilitation remain the unique possibilities to alleviate these challenging conditions. Among the emerging therapeutic odds, Pulsed Electromagnetic Fields (PEMFs) express anti-inflammatory and regenerative effects on musculoskeletal and parenchymal tissues. They have also shown intriguing properties to stimulate the central and peripheral nervous system either as Transcranial Magnetic Stimulation (TMS) and Low Frequency High-Intensity -Pulsed electromagnetic Field (LF-HI-PEMFs) or Diamagnetic Therapy (Diamagneto-therapy). This last modulates brain plasticity and is effective in pain, reducing muscles contractures and tissue oedema. Our experience refers to the use of Diamagnetic Therapy to rare and orphan diseases and reports promising functional and behavioural results, opening the possibility of therapeutic applications integrated with conventional rehabilitative methods. Journal of Neurology and Experimental Neural Science Obando FT, et al. J Neurol Exp Neural Sci 4: 145. www.doi.org/10.29011/2577-1442.100045 www.gavinpublishers.com Introduction Rare and orphan diseases are a group of pathologies that affect, by definition, small numbers of patients. The classification criteria are different in the various countries as there is no unified categorization globally accepted. According to the United States Rare Diseases Act (2002), a rare disease is a condition that affects about 1: 1500 person while the European Commission defines a rare disease as any disease that affects less than 1: 2000 people and some definitions rely on the existence of proper treatments [1]. Currently, despite their low prevalence, almost 8000 existing rare diseases are esteemed to affect about 350 million patients, with a worldwide impact on healthcare and the socio-economic systems in terms of direct and indirect costs. Recent progress in molecular biology, next-generation sequencing-based technologies, and genetics have enhanced the therapeutic choices: small-molecule drugs, protein-based therapeutics, antisense oligonucleotides, small interfering RNAs, gene and cell therapies [2] aim to trigger reparative molecular Citation: Obando FT, Romeo P, Vergara D, di Pardo F, Soto A (2022) The Effects of Low-Frequency High-Intensity Pulsed Electromagnetic Fields (Diamagnetic Therapy) in the Treatment of Rare Diseases: A Case Series Preliminary Study. J Neurol Exp Neural Sci 4: 145. DOI: 10.29011/2577-1442.100045 2 Volume 4; Issue 01 mechanisms. Nevertheless, there is still a lack of appropriate diagnostic tools and treatments that need more specific knowledge [3]. Thus, despite the growing interest in this field, the high costs related to the rarity of the d
罕见病和孤儿病是一组多器官残疾,限制了青年和成年患者的生活质量,影响了家庭和社区的社会经济负担。尽管研究不断尝试,但目前尚无标准化和有效的治疗方法。矫形器支持和康复仍然是缓解这些具有挑战性的条件的独特可能性。在新兴的治疗方法中,脉冲电磁场(pemf)对肌肉骨骼和实质组织具有抗炎和再生作用。它们还显示出刺激中枢和周围神经系统的有趣特性,如经颅磁刺激(TMS)和低频高强度脉冲电磁场(lf - hi - pemf)或抗磁疗法(Diamagneto-therapy)。这最后调节大脑的可塑性,是有效的疼痛,减少肌肉挛缩和组织水肿。我们的经验是使用抗磁疗法治疗罕见病和孤儿病,并报告了有希望的功能和行为结果,开辟了与传统康复方法相结合的治疗应用的可能性。《神经学与实验神经科学杂志》。中国生物医学工程学报(英文版),41(4):444 - 444。www.doi.org/10.29011/2577-1442.100045 www.gavinpublishers.com介绍罕见病和孤儿病是一组病理,根据定义,影响少数患者。由于没有全球公认的统一分类,各国的分类标准各不相同。根据美国《罕见病法》(2002年),罕见病是影响约1:15 500人的病症,而欧洲委员会将罕见病定义为影响少于1:2 000人的任何疾病,一些定义依赖于是否存在适当的治疗方法。目前,尽管发病率很低,但据估计,现有的近8000种罕见病影响了约3.5亿患者,在直接和间接成本方面对全球卫生保健和社会经济系统产生了影响。分子生物学、基于新一代测序技术和遗传学的最新进展增加了治疗选择:小分子药物、基于蛋白质的疗法、反义寡核苷酸、小干扰rna、基因和细胞疗法等,旨在触发修复分子。欧本多,王晓明,王晓明,等(2022)低频高强度脉冲电磁场(抗磁疗法)治疗罕见病的临床研究。中国生物医学工程学报(英文版),41(4):444 - 444。DOI: 10.29011/2577-1442.100045 2卷4;文档版本01机制。然而,仍然缺乏适当的诊断工具和治疗方法,需要更具体的知识。因此,尽管人们对这一领域的兴趣日益浓厚,但由于这些疾病的罕见性和其不明确的发病机制,其高昂的费用延缓了在特定治疗费用方面的进展。鉴于神经系统的频繁参与,最近的治疗尝试之一是生物物理刺激,其目标是改变特定大脑或外周区域的兴奋性和可塑性。重复经颅磁刺激(rTMS)是一种对大脑和神经系统进行电磁刺激的无创无痛技术。针对疼痛、运动障碍、中风、肌萎缩侧索硬化症、多发性硬化症、癫痫和其他疾病的实验证据,制定了适当的rTMS治疗指南。就其本身而言,脉冲电磁场(pemf)诱导的电磁刺激保留了世界公认的生物效应,在治疗疼痛和炎症以及再生医学,药物输送和免疫治疗方面都是有效的。pemf也已成功应用于肌肉骨骼疾病[6],以调节各种神经递质的活性和大脑皮层的可塑性[7,8]。由于常规治疗的反复无效,基于以往的经验,我们采用了一种新颖的PEMF技术来治疗一系列13例患有与罕见疾病相关的神经运动和行为障碍的患者。我们使用了一种基于低频高强度脉冲电磁场(LFHIPEMFs)的治疗方法,名为抗磁疗法(Diamagnetotherapy),取得了积极的效果。方法2019年5月至2021年4月,在哥伦比亚波哥大<e:1>细胞再生医疗组织,对13例年龄不同、患有不同神经肌肉罕见疾病的患者进行抗磁治疗。 其中肌营养不良2例,神经轴突营养不良1例,痉挛性脑瘫6例,出血性中风1例,左局灶性癫痫1例,肌张力障碍28例,Glass综合征1例,胼胝体发育不良1例,小脑桥发育不全1例,背腰椎发育不良1例。除了标准护理外,他们还使用了CTU Mega 20®Plus抗磁泵机(Periso SA - PazzalloSwitzerland)进行抗磁治疗的个性化治疗。根据疾病的症状和特征,卫生人员使用了不同的治疗方案。该技术提供高强度-低频电磁场(2.2 t - <50 Hz),并提供宽范围的磁场振幅和可变电磁频率,能够匹配身体组织的电磁特性,在细胞水平上刺激它们[8]。治疗区域的选择取决于疾病的发病机制。在中枢神经系统(CNS)的病理中,直接经颅刺激已被应用,如果涉及周围神经系统和肌肉(PNS),我们治疗有关的周围区域。与使用PEMF的传统技术一样,这些治疗的主要目标是刺激细胞的代谢活性。此外,CTU Mega 20 Plus机器提供了移动抗磁性物质的可能性,如水、离子和细胞外基质(ECM)的蛋白质,促进细胞水平的跨膜流动。此外,由于有可能根据生物组织的需要,有选择地改变电磁频率和磁场的振幅,激活肌肉装置,即慢速和快速神经纤维的电传导。表1总结了根据诊断、治疗方案和治疗范围、治疗次数为每位患者提供的治疗的主要特征。引用本文:Obando FT, Romeo P, Vergara D, di Pardo F, Soto A(2022)低频高强度脉冲电磁场(抗磁疗法)治疗罕见病的效果:病例系列初步研究。中国生物医学工程学报(英文版),41(4):444 - 444。DOI: 10.29011/2577-1442.100045 3 Volume 4;第01期患者诊断治疗区域抗磁治疗次数患者1肢带肌营养不良臀腰椎疼痛控制慢神经纤维刺激
{"title":"The Effects of Low-Frequency High-Intensity Pulsed Electromagnetic Fields (Diamagnetic Therapy) in the Treatment of Rare Diseases: A Case Series Preliminary Study","authors":"Felipe Torres Obando, P. Romeo, D. Vergara, Fede G Di, Pardo, Adriana Soto","doi":"10.29011/2577-1442.100045","DOIUrl":"https://doi.org/10.29011/2577-1442.100045","url":null,"abstract":"Rare and orphan diseases are a group of multiorgan disabilities that limit the life quality in young and adult patients, affecting the socio-economic burden for the families and the community. Despite the continuous attempts in research, no standardized and effective therapies are nowadays available. Orthosis supports and rehabilitation remain the unique possibilities to alleviate these challenging conditions. Among the emerging therapeutic odds, Pulsed Electromagnetic Fields (PEMFs) express anti-inflammatory and regenerative effects on musculoskeletal and parenchymal tissues. They have also shown intriguing properties to stimulate the central and peripheral nervous system either as Transcranial Magnetic Stimulation (TMS) and Low Frequency High-Intensity -Pulsed electromagnetic Field (LF-HI-PEMFs) or Diamagnetic Therapy (Diamagneto-therapy). This last modulates brain plasticity and is effective in pain, reducing muscles contractures and tissue oedema. Our experience refers to the use of Diamagnetic Therapy to rare and orphan diseases and reports promising functional and behavioural results, opening the possibility of therapeutic applications integrated with conventional rehabilitative methods. Journal of Neurology and Experimental Neural Science Obando FT, et al. J Neurol Exp Neural Sci 4: 145. www.doi.org/10.29011/2577-1442.100045 www.gavinpublishers.com Introduction Rare and orphan diseases are a group of pathologies that affect, by definition, small numbers of patients. The classification criteria are different in the various countries as there is no unified categorization globally accepted. According to the United States Rare Diseases Act (2002), a rare disease is a condition that affects about 1: 1500 person while the European Commission defines a rare disease as any disease that affects less than 1: 2000 people and some definitions rely on the existence of proper treatments [1]. Currently, despite their low prevalence, almost 8000 existing rare diseases are esteemed to affect about 350 million patients, with a worldwide impact on healthcare and the socio-economic systems in terms of direct and indirect costs. Recent progress in molecular biology, next-generation sequencing-based technologies, and genetics have enhanced the therapeutic choices: small-molecule drugs, protein-based therapeutics, antisense oligonucleotides, small interfering RNAs, gene and cell therapies [2] aim to trigger reparative molecular Citation: Obando FT, Romeo P, Vergara D, di Pardo F, Soto A (2022) The Effects of Low-Frequency High-Intensity Pulsed Electromagnetic Fields (Diamagnetic Therapy) in the Treatment of Rare Diseases: A Case Series Preliminary Study. J Neurol Exp Neural Sci 4: 145. DOI: 10.29011/2577-1442.100045 2 Volume 4; Issue 01 mechanisms. Nevertheless, there is still a lack of appropriate diagnostic tools and treatments that need more specific knowledge [3]. Thus, despite the growing interest in this field, the high costs related to the rarity of the d","PeriodicalId":73859,"journal":{"name":"Journal of neurology and experimental neural science","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48374692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.29011/2577-1442.000140
H. Ling
Introduction: Bell’s palsy (BP) is a loss of facial movement due to nerve damage. In traditional Chinese medicine (TCM), the physiopathology of BP is external Wind-Cold attacking the channels of the face. Purpose: To demonstrate which are the energy alterations on the chakras energy centers on patients with Bell’s palsy and the results of the treatment using TCM tools. Methods: Three case reports of patients with Bell’s palsy. All with history of developing Bell’s palsy after exposure to Cold and Wind. They received measurement of the chakras, and in all the cases, they had no energy in all seven chakras. The treatment was recommendation to avoid exposure to Cold and Wind, Chinese dietary counselling, acupuncture, and treatment for the chakras with homeopathy medication according to the theory of the author entitled Constitutional Homeopathy of the Five Elements based on Traditional Chinese Medicine and crystal-based medications. Results: All patients presented improvement of the Bell’s palsy, restoring nerve function, besides improving the ability of the patients to close their eyes and improvement of the well-being, self-esteem and emotional state. Conclusion: In this study, it was concluded that patients with Bell’s palsy have an energy deficiency on the chakras centers that make them more prone to invasion of Wind and Cold, due to weakened energy, leading, in this case, to the formation of Bell’s palsy. In this study, TCM tools were used for restoring the function of the facial nerves and muscles and rebalancing all the energy of the patients (Yin, Yang, Qi and Blood and chakras energy). The use of high-concentrated medication, such as corticosteroids, normally used in Western medicine treatment, may harm the vital energy of the patients even more, worsening or maintaining the condition of energy imbalance, and therefore, Bell’s palsy. Biography: Huang Wei Ling, born in Taiwan, raised in Brazil since the age of one, graduated in medicine in Brazil, specializing in infectious and parasitic diseases, General Practitioner, Parenteral and Enteral Medical Nutrition Therapist, Acupuncture and Pain Management Practitioner. Since 2007, she has been disseminating the knowledge of Oriental medicine, especially traditional Chinese medicine, in various places around the world, in the treatment of the various pathologies of the human body. Owner of Medical Acupuncture and Pain Management Clinic. Speaker Publications: 1. “The Importance of Correcting Chakras Energy Centers Alterations to Prevent Pacemaker Indication”. 2. “Energy Alterations Leading to Dyspnea in Patients with Mitral Valve Stenosis”. 3. “The Importance of Correcting Energy Imbalances in the Prevention and Treatment of Myocardial Infarction”. International Conference on Neurologists; WebinarNovember 27, 2020.
{"title":"Energy Alterations and Chakras Energy Deficiencies in the Pathophysiology of Bell’s Palsy","authors":"H. Ling","doi":"10.29011/2577-1442.000140","DOIUrl":"https://doi.org/10.29011/2577-1442.000140","url":null,"abstract":"Introduction: Bell’s palsy (BP) is a loss of facial movement due to nerve damage. In traditional Chinese medicine (TCM), the physiopathology of BP is external Wind-Cold attacking the channels of the face. Purpose: To demonstrate which are the energy alterations on the chakras energy centers on patients with Bell’s palsy and the results of the treatment using TCM tools. Methods: Three case reports of patients with Bell’s palsy. All with history of developing Bell’s palsy after exposure to Cold and Wind. They received measurement of the chakras, and in all the cases, they had no energy in all seven chakras. The treatment was recommendation to avoid exposure to Cold and Wind, Chinese dietary counselling, acupuncture, and treatment for the chakras with homeopathy medication according to the theory of the author entitled Constitutional Homeopathy of the Five Elements based on Traditional Chinese Medicine and crystal-based medications. Results: All patients presented improvement of the Bell’s palsy, restoring nerve function, besides improving the ability of the patients to close their eyes and improvement of the well-being, self-esteem and emotional state. Conclusion: In this study, it was concluded that patients with Bell’s palsy have an energy deficiency on the chakras centers that make them more prone to invasion of Wind and Cold, due to weakened energy, leading, in this case, to the formation of Bell’s palsy. In this study, TCM tools were used for restoring the function of the facial nerves and muscles and rebalancing all the energy of the patients (Yin, Yang, Qi and Blood and chakras energy). The use of high-concentrated medication, such as corticosteroids, normally used in Western medicine treatment, may harm the vital energy of the patients even more, worsening or maintaining the condition of energy imbalance, and therefore, Bell’s palsy. Biography: Huang Wei Ling, born in Taiwan, raised in Brazil since the age of one, graduated in medicine in Brazil, specializing in infectious and parasitic diseases, General Practitioner, Parenteral and Enteral Medical Nutrition Therapist, Acupuncture and Pain Management Practitioner. Since 2007, she has been disseminating the knowledge of Oriental medicine, especially traditional Chinese medicine, in various places around the world, in the treatment of the various pathologies of the human body. Owner of Medical Acupuncture and Pain Management Clinic. Speaker Publications: 1. “The Importance of Correcting Chakras Energy Centers Alterations to Prevent Pacemaker Indication”. 2. “Energy Alterations Leading to Dyspnea in Patients with Mitral Valve Stenosis”. 3. “The Importance of Correcting Energy Imbalances in the Prevention and Treatment of Myocardial Infarction”. International Conference on Neurologists; WebinarNovember 27, 2020.","PeriodicalId":73859,"journal":{"name":"Journal of neurology and experimental neural science","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69472216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.29011/2577-1442.000139
{"title":"Energy Disturbances in Panic Syndrome and How Can We Treat it in Adolescence?","authors":"","doi":"10.29011/2577-1442.000139","DOIUrl":"https://doi.org/10.29011/2577-1442.000139","url":null,"abstract":"","PeriodicalId":73859,"journal":{"name":"Journal of neurology and experimental neural science","volume":"54 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69471449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}